Drug Database
Back to search

Netherlands· NL-1cadeb47ebb7

Risedronaatnatrium Aurobindo 75 mg, filmomhulde tabletten

A risedronic acid product containing natriumrisedronaat 2,5-water + risedroninezuur, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC M05BA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRisedronaatnatrium Aurobindo 75 mg, f…ATCM05BA07REGISTER NO.NL-1cadeb47ebb7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about natriumrisedronaat 2,5-water + risedroninezuurAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Risedronic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC M05BA07 (risedronic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search risedronic acid products by name

Risedronic acid · ATC M05BA07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risedronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.45 in Italy to $1.17 in Switzerland — a ×2.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Risedronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.17
  • IT Italy$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NATRIUMRISEDRONAAT 2,5-WATER + RISEDRONINEZUUR
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
M05BA07
ATC class
Risedronic acid
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    116790

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

293 interactions on record for risedronic acid.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check risedronic acid against other medicinesHow interaction checks work

Risedronic acid · interactions on record

293 records

  • 2 severe
  • 68 moderate
  • 204 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • DeferasiroxV03AC03severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under M05BA07

Risedronic acid, as other registers publish it.

All risedronic acid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6529d72-6036-4fe0-bd14-d4619a9b0306
GET /v1/drugs/c6529d72-6036-4fe0-bd14-d4619a9b0306?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116790_smpc.pdf",
  "strength": null,
  "atc_label": "Risedronic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116790",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NATRIUMRISEDRONAAT 2,5-WATER",
    "RISEDRONINEZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116790.pdf",
  "authorised_at": "2016/02/15",
  "procedure_number": "NL/H/2263/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116790",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about risedronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console